Global Cancer Statistics 2022: the trends projection analysis

BS Chhikara, K Parang - Chemical Biology Letters, 2023 - pubs.thesciencein.org
Cancer is one of the most fatal diseases of recent times that causes several deaths every
year. The disease variations in different parts of the world, the impact of available medical …

[Retracted] Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures

D Kashyap, D Pal, R Sharma, VK Garg… - BioMed research …, 2022 - Wiley Online Library
Breast cancer is a global cause for concern owing to its high incidence around the world.
The alarming increase in breast cancer cases emphasizes the management of disease at …

2020 全球癌症统计报告解读

刘宗超, 李哲轩, 张阳, 周彤, 张婧莹, 游伟程… - 肿瘤综合治疗电子 …, 2021 - jmcm2018.com
2021 年1 月, 国际癌症研究机构团队在美国癌症学会旗下权威杂志《 临床医师癌症杂志》(CA: A
Cancer Journal for Clinicians) 发表了最新的全球癌症统计报告. 该报告阐述了2020 年36 …

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …

AR Lyon, T López-Fernández, LS Couch… - European Heart …, 2022 - academic.oup.com
ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

[HTML][HTML] Effect of colonoscopy screening on risks of colorectal cancer and related death

M Bretthauer, M Løberg, P Wieszczy… - … England Journal of …, 2022 - Mass Medical Soc
Background Although colonoscopy is widely used as a screening test to detect colorectal
cancer, its effect on the risks of colorectal cancer and related death is unclear. Methods We …

[HTML][HTML] Dostarlimab for primary advanced or recurrent endometrial cancer

MR Mirza, DM Chase, BM Slomovitz… - … England Journal of …, 2023 - Mass Medical Soc
Background Dostarlimab is an immune-checkpoint inhibitor that targets the programmed cell
death 1 receptor. The combination of chemotherapy and immunotherapy may have …

[HTML][HTML] Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer

LA Rojas, Z Sethna, KC Soares, C Olcese, N Pang… - Nature, 2023 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is lethal in 88% of patients, yet harbours
mutation-derived T cell neoantigens that are suitable for vaccines,. Here in a phase I trial of …

Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN

E Morgan, M Arnold, A Gini, V Lorenzoni, CJ Cabasag… - Gut, 2023 - gut.bmj.com
Objective Colorectal cancer (CRC) is the third most common cancer worldwide. The
geographical and temporal burden of this cancer provides insights into risk factor …

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer …

RK Kelley, M Ueno, C Yoo, RS Finn, J Furuse, Z Ren… - The Lancet, 2023 - thelancet.com
Background Biliary tract cancers, which arise from the intrahepatic or extrahepatic bile ducts
and the gallbladder, generally have a poor prognosis and are rising in incidence worldwide …

Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆

A Cervantes, R Adam, S Roselló, D Arnold… - Annals of …, 2023 - annalsofoncology.org
Colorectal cancer (CRC) is the third most common cancer worldwide, with 1.1 million new
cases per year, and is the second leading cause of cancer death. 1 CRC occurs more …